{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:08:01Z","timestamp":1772068081172,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.cyto.2008.06.006","type":"journal-article","created":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T08:34:42Z","timestamp":1217406882000},"page":"49-56","source":"Crossref","is-referenced-by-count":17,"title":["Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-\u03b1 in an experimental murine model of colitis"],"prefix":"10.1016","volume":"44","author":[{"given":"Jienny","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Sunny","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Young","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Yeon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon-Hyuck","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Won","family":"Joh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2008.06.006_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-0012.1996.tb00651.x","article-title":"Purine metabolism and immunosuppressive effects of mycophenolate mofetil","volume":"10","author":"Allison","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cyto.2008.06.006_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1399-0012.1996.tb00659.x","article-title":"Mycophenolate mofetil for maintenance therapy in kidney transplantation","volume":"10","author":"Gonwa","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cyto.2008.06.006_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1399-0012.1996.tb00652.x","article-title":"From mice to man: the preclinical history of mycophenolate mofetil","volume":"10","author":"Sollinger","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cyto.2008.06.006_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0272-6386(96)90297-8","article-title":"Immunosuppressants: cellular and molecular mechanisms of action","volume":"28","author":"Suthanthiran","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cyto.2008.06.006_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0190-9622(87)70285-0","article-title":"Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety","volume":"17","author":"Epinette","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 8","key":"10.1016\/j.cyto.2008.06.006_bib6","first-page":"S117","article-title":"Therapy of rheumatoid arthritis with mycophenolate mofetil","volume":"11","author":"Goldblum","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cyto.2008.06.006_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0014-4835(05)80138-1","article-title":"Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism","volume":"61","author":"Chanaud","year":"1995","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cyto.2008.06.006_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-6632.1993.tb17168.x","article-title":"Mycophenolate mofetil can prevent the development of diabetes in BB rats","volume":"696","author":"Hao","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cyto.2008.06.006_bib9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1046\/j.1365-2249.1999.00901.x","article-title":"Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr\/lpr mice","volume":"116","author":"Jonnson","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/ki.1997.217","article-title":"Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease","volume":"51","author":"Corna","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.cyto.2008.06.006_bib11","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1681\/ASN.V9122272","article-title":"Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition","volume":"9","author":"Penny","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cyto.2008.06.006_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/gut.44.5.625","article-title":"Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn\u2019s disease","volume":"44","author":"Neurath","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2008.06.006_bib13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(96)10310-X","article-title":"Mycophenolate mofetil","volume":"348","author":"Lipsky","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2008.06.006_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/00365520150218075","article-title":"Mycophenolate mofetil reduces tissue damage and inflammation in an experimental model of colitis in rats","volume":"36","author":"Zeeh","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cyto.2008.06.006_bib15","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/S0041-1345(02)03538-8","article-title":"Mechanisms of action of mycophenolate mofetil in preventing chronic rejection","volume":"34","author":"Allison","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cyto.2008.06.006_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0966-3274(96)80039-6","article-title":"Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allograft","volume":"4","author":"Heemann","year":"1996","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1523-1755.2003.00736.x","article-title":"Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes","volume":"63","author":"Utimura","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.cyto.2008.06.006_bib18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/gast.2001.22122","article-title":"IBD: immunodiagnostics, immunotherapeutics, and ectotherapeutics","volume":"120","author":"Shanahan","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2008.06.006_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/1074-7613(94)90045-0","article-title":"Inhibition of Th1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45RBhi CD4+ T cells","volume":"1","author":"Powrie","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2008.06.006_bib20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.190.10.1479","article-title":"Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2\u2212\/\u2212 mice upon transfer of CD4+ CD45RBhi T cells","volume":"190","author":"Corazza","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2008.06.006_bib21","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.4049\/jimmunol.169.11.6187","article-title":"Autocrine IL-15 mediates intestinal epithelial cell death via the activation of neighboring intraepithelial NK cells","volume":"169","author":"Kinoshita","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/gast.2000.16485","article-title":"Chronic murine colitis is dependent on the CD154\/CD40 pathway and can be attenuated by anti-CD154 administration","volume":"119","author":"De Jong","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2008.06.006_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI200420855","article-title":"Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease","volume":"114","author":"Olson","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2008.06.006_bib24","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4049\/jimmunol.161.3.1348","article-title":"MD-1, a molecule that is physically associated with RP105 and positively regulates its expression","volume":"161","author":"Miyake","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib25","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/gast.2002.33426","article-title":"Biologic therapy of IBD","volume":"122","author":"Sandborn","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2008.06.006_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-3083.2000.00657.x","article-title":"Immunotherapy of Crohn\u2019s disease","volume":"51","author":"Van Deventer","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM199603283341307","article-title":"Inflammatory bowel disease","volume":"334","author":"Hanauer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2008.06.006_bib28","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1053\/j.gastro.2004.03.015","article-title":"Colitis is associated with thymic destruction attenuating CD4+ CD25+ regulatory T cells in the periphery","volume":"126","author":"Faubion","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2008.06.006_bib29","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.173.5.3119","article-title":"CD4+ CD25bright T cells in human intestinal lamina propria as regulatory cells","volume":"173","author":"Makita","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-kappa B in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib31","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2008.06.006_bib32","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.4049\/jimmunol.163.6.3474","article-title":"Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity","volume":"163","author":"Jobin","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1993.tb05997.x","article-title":"Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn\u2019s disease","volume":"94","author":"Reinecker","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002689900401","article-title":"Cytokines in inflammatory bowel disease","volume":"22","author":"Rogler","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.cyto.2008.06.006_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1152\/ajpcell.00113.2001","article-title":"MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism","volume":"283","author":"Jijon","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cyto.2008.06.006_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(01)78001-7","article-title":"Toll-like receptors and innate immunity","volume":"78","author":"Akira","year":"2001","journal-title":"Adv Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib37","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/00007890-200206150-00013","article-title":"Antisense deoxyoligonucleotides or antibodies to murine MD-1 inhibit rejection of allogeneic and xenogeneic skin grafts in C3H mice","volume":"73","author":"Hadidi","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.cyto.2008.06.006_bib38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35021228","article-title":"Toll-like receptors in the induction of the innate immune response","volume":"406","author":"Aderem","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2008.06.006_bib39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni1198","article-title":"Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105","volume":"6","author":"Divanovic","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2008.06.006_bib41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1084\/jem.20021633","article-title":"Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide","volume":"197","author":"Caramalho","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2008.06.006_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1084\/jem.188.1.93","article-title":"The molecular mechanism of B cell activation by toll-like receptor protein RP-105","volume":"188","author":"Chan","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2008.06.006_bib43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1084\/jem.187.5.663","article-title":"B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells","volume":"187","author":"Grumont","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2008.06.006_bib44","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1107","article-title":"4-1BB-mediated immunotherapy of rheumatoid arthritis","volume":"10","author":"Seo","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.cyto.2008.06.006_bib45","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cyto.2008.06.006_bib46","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat Immunol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346660800183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346660800183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T07:00:39Z","timestamp":1738306839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346660800183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S104346660800183X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2008.06.006","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}